Login

Elis, Rings European Trading Day in Paris | Xavier Martiré - Chairman of the Management Board and Chief Executive Officer of Elis SA 00:10:00

Share On Facebook Share On Twitter

Xavier Martire is Chairman-Mgmt Board/CEO at Elis SA.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Expansion and Optimization of Vein Density at Sera Verde Project
00:10:00
Ari Kahn and John Murcott Explore AI's Impact on Search and Merchandising | Ari Kahn, CEO , Bridgeline Digital Inc.
00:10:00
Unlocking Your Path: From Aspiring Engineer to Thriving in Diverse Industries | David Lockwood OBE - CEO of Babcock International
00:10:00
CEO Discusses Wind Generation Challenges and Market Dynamics, Forecasts Optimistic Outlook for Second Semester| Rogério Pereira Jorge , CEO, AES Brasil Energia SA.
00:10:00
Thank you, Mr. Malcolm Deane, CEO and Managing Director of ALS, for presenting at our latest Morgans Business Breakfast.|Mr. Malcolm Deane, CEO and Managing Director of ALS
00:10:00
Sierra Metals: Expanding Operations and Strategic Plans for Growth
00:10:00
Living with Purpose: Inspiring Youth and Transforming Communities | William H. Rogers Jr, Chairman ,  Truist Financial.
00:10:00
Gene Sheridan, Co-Founder and CEO of Navitas Semiconductor, explores the influence of AI on the semiconductor industry landscape.|Gene Sheridan, CEO of Navitas Semiconductor
00:10:00
Tony Pidgley on How Smaller Developers Can Emulate Berkeley Group's Success | Tony Pidgley, Chairman , Berkeley Group Holdings Plc.
00:10:00
OTB Ventures is a venture capital fund investing in technology|Marcin Hejka,Co-Founder and General Partner,OTB Ventures
00:00:00
Inorganic Nitrate Benefits and Tolerability of Exercise Training - Dr. Barry Borlaug, a Cardiologist and Heart Failure Specialist at Mayo Clinic
00:10:00
Builders FirstSource CEO David Flitman on Lumber Supply Challenges and Market Outlook | David Flitman , CEO, Builders FirstSource Inc.

© 2017 - Neuhu+